Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD

INTRODUCTION: Heart disease in chronic obstructive pulmonary disease (COPD) is a common but neglected comorbidity. Patients with COPD are frequently excluded from clinical trials of treatments aimed at reducing cardiac morbidity and mortality, which has led to undertreatment of cardiovascular diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Allison, Hancox, Robert J, Chang, Catherina L, Beasley, Richard, Wrobel, Jeremy, McDonald, Vanessa, Dobler, Claudia C, Yang, Ian A, Farah, Claude S, Cochrane, Belinda, Hillis, Graham S, Scowcroft, Caroline Polak, Aggarwal, Ashutosh, Di Tanna, Gian Luca, Balicki, Grace, Galgey, Shane, Jenkins, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404458/
https://www.ncbi.nlm.nih.gov/pubmed/34452971
http://dx.doi.org/10.1136/bmjopen-2021-053446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404458/
https://www.ncbi.nlm.nih.gov/pubmed/34452971
http://dx.doi.org/10.1136/bmjopen-2021-053446

Ejemplares similares